Lachlan Pharma Holdings Report issue

For profit Phase 3
Founded: Dublin Ireland (2014)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2017
NCT03116737
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now